Insider Transactions in Q1 2024 at Inspire Medical Systems, Inc. (INSP)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 27
2024
|
Marilyn C Nelson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,243
+5.07%
|
$366,459
$113.64 P/Share
|
|
Mar 25
2024
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
554
-2.49%
|
$109,138
$197.81 P/Share
|
|
Mar 25
2024
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+8.2%
|
$16,000
$16.0 P/Share
|
|
Mar 22
2024
|
John Rondoni Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
4,387
-10.05%
|
$851,078
$194.46 P/Share
|
|
Mar 18
2024
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
554
-2.59%
|
$106,922
$193.53 P/Share
|
|
Mar 18
2024
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+8.52%
|
$16,000
$16.0 P/Share
|
|
Mar 11
2024
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
554
-2.7%
|
$109,692
$198.05 P/Share
|
|
Mar 11
2024
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+8.85%
|
$16,000
$16.0 P/Share
|
|
Mar 01
2024
|
Marilyn C Nelson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,555
+8.41%
|
$0
$0.94 P/Share
|
|
Mar 01
2024
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
554
-3.12%
|
$99,166
$179.44 P/Share
|
|
Mar 01
2024
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+9.21%
|
$16,000
$16.0 P/Share
|
|
Feb 29
2024
|
John Rondoni Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
8,605
-9.74%
|
$1,540,295
$179.61 P/Share
|
|
Feb 27
2024
|
Randy Ban Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,060
-50.25%
|
$556,920
$182.01 P/Share
|
|
Feb 27
2024
|
Randy Ban Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,060
+33.45%
|
$128,520
$42.15 P/Share
|
|
Feb 23
2024
|
Randy Ban Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
12,230
-80.15%
|
$2,262,550
$185.37 P/Share
|
|
Feb 23
2024
|
Randy Ban Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,230
+24.94%
|
$256,830
$21.55 P/Share
|
|
Feb 15
2024
|
John Rondoni Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+24.8%
|
$16,000
$2.07 P/Share
|
|
Feb 09
2024
|
Randy Ban Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,694
+47.07%
|
-
|
|
Feb 09
2024
|
Bryan K Phillips Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,694
+37.08%
|
-
|
|
Feb 09
2024
|
Philip Ebeling Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,694
+47.09%
|
-
|
|
Feb 09
2024
|
John Rondoni Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,694
+14.21%
|
-
|
|
Feb 09
2024
|
Richard Buchholz Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,694
+5.86%
|
-
|
|
Feb 09
2024
|
Charisse Y Sparks Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,694
+42.19%
|
-
|
|
Feb 09
2024
|
Timothy P. Herbert CEO, President & Chairperson |
BUY
Grant, award, or other acquisition
|
Direct |
8,467
+46.63%
|
-
|
|
Feb 09
2024
|
Carlton Weatherby Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,694
+50.0%
|
-
|
|
Feb 09
2024
|
Marilyn C Nelson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+13.67%
|
$0
$0.94 P/Share
|
|
Jan 30
2024
|
Steven Jandrich VP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
16,225
+41.26%
|
$0
$0.94 P/Share
|
|
Jan 29
2024
|
Bryan K Phillips Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
205
-9.85%
|
$44,280
$216.61 P/Share
|
|
Jan 16
2024
|
Charisse Y Sparks Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5
+0.28%
|
$1,190
$238.19 P/Share
|
|
Jan 16
2024
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
97
+2.04%
|
$21,340
$220.83 P/Share
|
|
Jan 16
2024
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
97
+0.98%
|
$21,340
$220.83 P/Share
|
|
Jan 16
2024
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
167
+0.26%
|
$36,740
$220.83 P/Share
|
|
Jan 16
2024
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
90
+2.16%
|
$19,800
$220.83 P/Share
|
|
Jan 16
2024
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
87
+0.15%
|
$19,140
$220.83 P/Share
|